BCL2/adenovirus E1B 19kD Interacting Protein Like (BNIPL) (Middle Region) Peptid
BNIPL
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle BNIPL Produkte
- BNIPL (BCL2/adenovirus E1B 19kD Interacting Protein Like (BNIPL))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- AENYLLVHLS GGTSRAQVPP LSWIRQCYRT LDRRLRKNLR ALVVVHATWY
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-BNIPL Antibody(ARP52577_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- BNIPL (BCL2/adenovirus E1B 19kD Interacting Protein Like (BNIPL))
- Hintergrund
-
BNIPL may be a bridge molecule between BCL2 and ARHGAP1/CDC42 in promoting cell death.
Alias Symbols: BNIP-S, BNIPL-1, BNIPL-2, PP753
Protein Interaction Partner: ARHGAP1,BCL2,BNIPL,ARHGAP1,BNIP2,BNIPL,GFER,MIF,ARHGAP1,BCL2,BNIP2,BNIPL,GFER,MIF,ARHGAP1,BAX,BCL2,BCL2L1,BNIP2,BNIPL,CDC42,GFER,MIF
Protein Size: 357 - Molekulargewicht
- 40 kDa
- Gen-ID
- 149428
- NCBI Accession
- NM_138278, NP_612122
- UniProt
- Q7Z465
-
Sie sind hier:
